THE USE OF DEUTERIUM ISOTOPE EFFECTS TO PROBE THE ACTIVE SITE PROPERTIES, MECHANISM OF CYTOCHROME P450-CATALYZED REACTIONS, AND MECHANISMS OF METABOLICALLY DEPENDENT TOXICITY
Critical elements from studies that have led to our current understanding of the factors that cause the observed primary deuterium isotope effect, (k H /k D )obs, of most enzymatically mediated reactions to be much smaller than the âtrueâ or intrinsic primary deuterium isotope effect, k H /k D ,...
Saved in:
Published in: | Drug metabolism and disposition Vol. 31; no. 12; pp. 1481 - 1498 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
Bethesda, MD
American Society for Pharmacology and Experimental Therapeutics
01-12-2003
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Critical elements from studies that have led to our current understanding of the factors that cause the observed primary deuterium
isotope effect, (k H /k D )obs, of most enzymatically mediated reactions to be much smaller than the âtrueâ or intrinsic primary deuterium isotope effect,
k H /k D , for the reaction are presented. This new understanding has provided a unique and powerful tool for probing the catalytic
and active site properties of enzymes, particularly the cytochromes P450 (P450). Examples are presented that illustrate how
the technique has been used to determine k H /k D , and properties such as the catalytic nature of the reactive oxenoid intermediate, prochiral selectivity, the chemical and
enzymatic mechanisms of cytochrome P450-catalyzed reactions, and the relative active site size of different P450 isoforms.
Examples are also presented of how deuterium isotope effects have been used to probe mechanisms of the formation of reactive
metabolites that can cause toxic effects. |
---|---|
AbstractList | Critical elements from studies that have led to our current understanding of the factors that cause the observed primary deuterium
isotope effect, (k H /k D )obs, of most enzymatically mediated reactions to be much smaller than the âtrueâ or intrinsic primary deuterium isotope effect,
k H /k D , for the reaction are presented. This new understanding has provided a unique and powerful tool for probing the catalytic
and active site properties of enzymes, particularly the cytochromes P450 (P450). Examples are presented that illustrate how
the technique has been used to determine k H /k D , and properties such as the catalytic nature of the reactive oxenoid intermediate, prochiral selectivity, the chemical and
enzymatic mechanisms of cytochrome P450-catalyzed reactions, and the relative active site size of different P450 isoforms.
Examples are also presented of how deuterium isotope effects have been used to probe mechanisms of the formation of reactive
metabolites that can cause toxic effects. Critical elements from studies that have led to our current understanding of the factors that cause the observed primary deuterium isotope effect, (k sub(H)/k sub(D))obs, of most enzymatically mediated reactions to be much smaller than the "true" or intrinsic primary deuterium isotope effect, k sub(H)/k sub(D), for the reaction are presented. This new understanding has provided a unique and powerful tool for probing the catalytic and active site properties of enzymes, particularly the cytochromes P450 (P450). Examples are presented that illustrate how the technique has been used to determine k sub(H)/k sub(D), and properties such as the catalytic nature of the reactive oxenoid intermediate, prochiral selectivity, the chemical and enzymatic mechanisms of cytochrome P450-catalyzed reactions, and the relative active site size of different P450 isoforms. Examples are also presented of how deuterium isotope effects have been used to probe mechanisms of the formation of reactive metabolites that can cause toxic effects. Critical elements from studies that have led to our current understanding of the factors that cause the observed primary deuterium isotope effect, (kH/kD)obs, of most enzymatically mediated reactions to be much smaller than the "true" or intrinsic primary deuterium isotope effect, kH/kD, for the reaction are presented. This new understanding has provided a unique and powerful tool for probing the catalytic and active site properties of enzymes, particularly the cytochromes P450 (P450). Examples are presented that illustrate how the technique has been used to determine kH/kD, and properties such as the catalytic nature of the reactive oxenoid intermediate, prochiral selectivity, the chemical and enzymatic mechanisms of cytochrome P450-catalyzed reactions, and the relative active site size of different P450 isoforms. Examples are also presented of how deuterium isotope effects have been used to probe mechanisms of the formation of reactive metabolites that can cause toxic effects. |
Author | William F. Trager Sidney D. Nelson |
Author_xml | – sequence: 1 givenname: Sidney D surname: NELSON fullname: NELSON, Sidney D organization: Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, Washington, United States – sequence: 2 givenname: William F surname: TRAGER fullname: TRAGER, William F organization: Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, Washington, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15322095$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/14625345$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkc2K2zAUhUWZ0slMu-2yaNN2U7v68U-09DhKY7CtYCtl0o1RFHmSwY5Te0KZl-ozViaBdHXh8n3nXjh34ObQHQwAHzFyMSbe9227dSl2MXGxN8VvwAT7BDsIsccbMLEDOcz3g1twNwzPCGHPo-wduMVeQHzq-RPwVy44XJUcijmc8ZXkRbLKYFIKKZYc8vmcx7KEUsBlIR44HOkolslPDstE8nG75IVMePkNZjxeRHlSZmNWvJYiXhQis4znIyeOZJSuf_EZLPgYIHJrRPnsapWjlnEZPYg0iaM0XduHljyf8VzaBx6TOJHr9-BtrZrBfLjMe7CacxkvnFT8GCVH22MvToD9EBmjMaIsZIxM6ZSh7SYglKDAR6hGXkioJpbzQm3MlIWk1kpvsFIB1oTegy_n3GPf_T6Z4aVq94M2TaMOpjsNFQ4ZClkQWNA9g7rvhqE3dXXs963qXyuMqrGhyjZUUVxhUo0NWeHTJfm0ac32il8qscDnC6AGrZq6Vwe9H66cTwlBbOS-nrnd_mn3Z9-b6rhTfat013RPr_-f_Ac6XJlj |
CODEN | DMDSAI |
CitedBy_id | crossref_primary_10_1021_acs_jmedchem_8b01808 crossref_primary_10_1002_anie_200700039 crossref_primary_10_1021_bi300895w crossref_primary_10_1007_s00280_020_04031_1 crossref_primary_10_1002_jps_23295 crossref_primary_10_1016_S2213_2600_22_00504_5 crossref_primary_10_1111_j_1365_2125_2011_04071_x crossref_primary_10_1039_D1MD00245G crossref_primary_10_1074_jbc_M109_040857 crossref_primary_10_1124_jpet_117_241497 crossref_primary_10_1021_acscatal_6b01170 crossref_primary_10_1021_jm901023f crossref_primary_10_1021_bi8005658 crossref_primary_10_1016_j_bbrc_2006_11_071 crossref_primary_10_3109_03602532_2014_1001029 crossref_primary_10_1111_cbdd_13321 crossref_primary_10_1021_ol3012869 crossref_primary_10_1021_tx900105n crossref_primary_10_1371_journal_pone_0087058 crossref_primary_10_1016_j_isci_2019_06_007 crossref_primary_10_1021_jm4007998 crossref_primary_10_1007_s11030_017_9742_y crossref_primary_10_1021_cr020443g crossref_primary_10_2174_0929867330666221122123201 crossref_primary_10_1016_j_talanta_2018_03_016 crossref_primary_10_1021_jacs_1c00884 crossref_primary_10_3390_ma6020392 crossref_primary_10_1007_s11030_016_9660_4 crossref_primary_10_1248_cpb_c17_00222 crossref_primary_10_1038_s41586_020_2268_y crossref_primary_10_1002_adsc_201600363 crossref_primary_10_1002_ange_201704146 crossref_primary_10_1021_jm400439t crossref_primary_10_18311_jnr_2023_31386 crossref_primary_10_1021_ja0562651 crossref_primary_10_1016_j_jchromb_2014_05_043 crossref_primary_10_1124_dmd_114_059626 crossref_primary_10_1021_jacsau_4c00185 crossref_primary_10_1002_cphc_201901092 crossref_primary_10_1021_acs_jmedchem_7b01664 crossref_primary_10_1002_mrm_29166 crossref_primary_10_1016_j_cclet_2023_108454 crossref_primary_10_1002_anie_201704146 crossref_primary_10_1021_bi702020y crossref_primary_10_1016_j_atherosclerosis_2017_07_018 crossref_primary_10_1016_j_bmcl_2022_128879 crossref_primary_10_1021_jacs_8b12874 crossref_primary_10_1016_j_bmc_2023_117533 crossref_primary_10_1124_jpet_122_001462 crossref_primary_10_3390_antiox9090772 crossref_primary_10_1124_dmd_111_042770 crossref_primary_10_1002_jat_2879 crossref_primary_10_1016_j_bmcl_2019_04_019 crossref_primary_10_1002_chem_202100635 crossref_primary_10_1021_acs_oprd_8b00383 crossref_primary_10_1111_j_1742_4658_2011_08285_x crossref_primary_10_1038_s41467_020_18458_w crossref_primary_10_1002_slct_202204628 crossref_primary_10_4155_bio_12_242 crossref_primary_10_1002_cpdd_1040 crossref_primary_10_1021_jacsau_3c00053 crossref_primary_10_1021_ic501737j crossref_primary_10_1002_ange_201804794 crossref_primary_10_1021_tx800093k crossref_primary_10_1007_s11030_018_9875_7 crossref_primary_10_1002_aoc_7602 crossref_primary_10_1021_acs_chemrev_7b00373 crossref_primary_10_1124_dmd_116_071753 crossref_primary_10_1074_jbc_M708950200 crossref_primary_10_1124_dmd_114_057265 crossref_primary_10_1111_febs_15116 crossref_primary_10_3390_molecules21030318 crossref_primary_10_1021_jacs_2c00608 crossref_primary_10_1124_jpet_115_223768 crossref_primary_10_1016_j_jbc_2022_101795 crossref_primary_10_1002_ijc_33706 crossref_primary_10_1021_tx800139z crossref_primary_10_1016_j_bmc_2013_03_038 crossref_primary_10_1124_dmd_115_067181 crossref_primary_10_1039_C5PY00278H crossref_primary_10_1146_annurev_pharmtox_45_120403_100004 crossref_primary_10_1002_jlcr_3081 crossref_primary_10_1021_tx060093j crossref_primary_10_1016_j_bioorg_2023_106490 crossref_primary_10_1016_j_xcrp_2024_101843 crossref_primary_10_1039_D0SC02661A crossref_primary_10_1007_s11745_011_3612_7 crossref_primary_10_1016_j_aca_2016_05_003 crossref_primary_10_1021_jm1013693 crossref_primary_10_1002_jlcr_3516 crossref_primary_10_1002_jlcr_1578 crossref_primary_10_1016_j_ejmech_2020_112631 crossref_primary_10_1021_acs_orglett_7b00683 crossref_primary_10_1016_j_crci_2013_05_001 crossref_primary_10_1073_pnas_1417832112 crossref_primary_10_1021_jp206570n crossref_primary_10_1038_s41573_023_00703_8 crossref_primary_10_1002_ange_200700039 crossref_primary_10_1002_adsc_201800170 crossref_primary_10_1016_j_ejmech_2013_02_001 crossref_primary_10_1021_acs_jpclett_6b01235 crossref_primary_10_1021_bi401472p crossref_primary_10_1080_03602532_2021_1970178 crossref_primary_10_2320_matertrans_48_730 crossref_primary_10_1016_j_bmc_2015_03_065 crossref_primary_10_1016_j_bmc_2017_10_040 crossref_primary_10_1016_j_bioorg_2017_12_012 crossref_primary_10_1039_C4RA16386A crossref_primary_10_1177_1060028018797110 crossref_primary_10_1124_dmd_110_032755 crossref_primary_10_1002_anie_201804794 crossref_primary_10_1002_chem_202104340 crossref_primary_10_1016_j_ddtec_2012_09_011 crossref_primary_10_1007_s13361_014_1064_z crossref_primary_10_1016_j_aca_2019_02_025 |
Cites_doi | 10.1016/0006-2952(69)90050-1 10.1093/carcin/2.8.731 10.1021/cr60211a004 10.1021/bi00517a017 10.1016/0024-3205(86)90191-8 10.1021/bi010395e 10.1002/hep.1840040609 10.1016/0006-291X(77)90758-6 10.1007/978-1-4684-5877-0_9 10.1093/mutage/4.5.355 10.1021/ja00214a060 10.1021/bi00449a009 10.1021/tx9501187 10.1021/ja00118a001 10.1016/0024-3205(78)90668-9 10.1097/00000542-197909001-00105 10.7326/0003-4819-124-8-199604150-00004 10.1021/ja00218a045 10.1021/bi00531a026 10.1016/0006-2952(78)90143-0 10.1021/bi00371a015 10.1021/jm00196a009 10.1016/0006-291X(78)91643-1 10.1289/ehp.7721165 10.1021/bi00683a013 10.1093/carcin/15.8.1487 10.1021/bi00472a030 10.1016/0041-008X(88)90388-2 10.1093/carcin/4.7.821 10.1021/tx00011a001 10.1016/0014-5793(96)00267-0 10.3109/10409238209108715 10.1016/0006-291X(84)90709-5 10.1021/ja00246a038 10.1006/faat.1995.1152 10.1093/carcin/12.4.545 10.1016/0003-9861(83)90178-9 10.1021/bi000869u 10.1021/ja983000w 10.1039/cs9740300513 10.3109/00498259209051869 10.1021/ja00310a066 10.1016/S0021-9258(18)43699-X 10.1021/tx00004a001 10.1016/0009-2797(79)90077-2 10.1016/0041-008X(81)90363-X 10.1016/0041-008X(82)90387-8 10.1021/ja00354a044 10.1016/S0300-483X(01)00376-6 10.1016/0009-2797(74)90128-8 10.1093/jnci/68.4.681 10.1006/bioo.2002.1239 10.1016/0165-1161(77)90003-6 10.1093/carcin/5.8.1009 10.1016/0300-483X(95)03116-W 10.1016/0041-008X(83)90297-1 10.1021/ja00074a001 10.1021/bi00176a025 10.1016/0041-008X(85)90089-4 10.1021/bi00176a024 10.1016/0006-2952(80)90624-3 10.1093/jnci/57.6.1311 10.1002/1097-0142(197512)36:6<2407::AID-CNCR2820360620>3.0.CO;2-W 10.1016/0041-008X(83)90310-1 10.1021/tx0100237 10.1093/carcin/6.6.873 10.1006/taap.1994.1193 10.1016/0041-008X(87)90306-1 10.1016/0009-2797(75)90098-8 10.1016/0165-1161(78)90016-X 10.1080/15287398109530054 10.1021/jm00229a019 10.1093/carcin/15.6.1197 10.1016/0163-7258(85)90072-5 10.1016/0024-3205(91)90573-T 10.1097/00005072-199211000-00001 10.1016/0304-3835(84)90023-5 10.1146/annurev.bi.50.070181.000535 10.1021/bi00405a033 10.3109/00498259209051870 10.3109/03602539509029814 10.1021/tx00046a010 10.1021/jm00166a024 10.1093/carcin/3.11.1289 10.1016/S0021-9258(18)68302-4 10.1016/S0021-9258(17)43249-2 10.1021/tx00013a011 10.1093/jnci/51.1.299 |
ContentType | Journal Article |
Copyright | 2004 INIST-CNRS |
Copyright_xml | – notice: 2004 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7U7 C1K |
DOI | 10.1124/dmd.31.12.1481 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Toxicology Abstracts Environmental Sciences and Pollution Management |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Toxicology Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | Toxicology Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1521-009X |
EndPage | 1498 |
ExternalDocumentID | 10_1124_dmd_31_12_1481 14625345 15322095 31_12_1481 |
Genre | Journal Article Review |
GroupedDBID | - 08R 0R 2WC 53G 5GY 5RE 5VS AAPBV AAWZA ABFLS ABSGY ACGFS ACIWK ACPRK ADACO AENEX AFFNX AFRAH ALMA_UNASSIGNED_HOLDINGS CS3 DIK DU5 E3Z EBS EJD F5P FH7 FRP GJ GX1 H13 HZ IH2 INIJC KM KQ8 LSO O0- O9- OK1 P2P R0Z RHF RHI RPT SJN VH1 W2D WH7 WOQ ZGI ZXP --- .GJ 0R~ 18M 4.4 ABSQV ACGFO ADBBV AFOSN AI. BAWUL BTFSW F9R HZ~ IQODW TR2 W8F YCJ YHG ~KM ABJNI AERNN CGR CUY CVF ECM EIF NPM AAYXX CITATION 7U7 C1K |
ID | FETCH-LOGICAL-c450t-61570eec1039799283890db623206500f04723c261547cee8972fcacb1aa61c23 |
ISSN | 0090-9556 |
IngestDate | Fri Aug 16 21:00:40 EDT 2024 Fri Aug 23 02:56:13 EDT 2024 Sat Sep 28 07:42:15 EDT 2024 Sun Oct 22 16:07:18 EDT 2023 Tue Jan 05 21:17:00 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Deuterium Isotope effect Investigation method Isozyme Metabolite Toxicity Cytochrome P450 Active site Reagents Reaction mechanism Review Mechanism of action |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c450t-61570eec1039799283890db623206500f04723c261547cee8972fcacb1aa61c23 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 14625345 |
PQID | 17907966 |
PQPubID | 23462 |
PageCount | 18 |
ParticipantIDs | proquest_miscellaneous_17907966 crossref_primary_10_1124_dmd_31_12_1481 pubmed_primary_14625345 pascalfrancis_primary_15322095 highwire_pharmacology_31_12_1481 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 2000 |
PublicationDate | 2003-12-01 |
PublicationDateYYYYMMDD | 2003-12-01 |
PublicationDate_xml | – month: 12 year: 2003 text: 2003-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Bethesda, MD |
PublicationPlace_xml | – name: Bethesda, MD – name: United States |
PublicationTitle | Drug metabolism and disposition |
PublicationTitleAlternate | Drug Metab Dispos |
PublicationYear | 2003 |
Publisher | American Society for Pharmacology and Experimental Therapeutics |
Publisher_xml | – name: American Society for Pharmacology and Experimental Therapeutics |
References | 2019091113313166000_31.12.1481.63 2019091113313166000_31.12.1481.110 2019091113313166000_31.12.1481.62 2019091113313166000_31.12.1481.61 2019091113313166000_31.12.1481.60 2019091113313166000_31.12.1481.117 2019091113313166000_31.12.1481.115 2019091113313166000_31.12.1481.69 2019091113313166000_31.12.1481.116 2019091113313166000_31.12.1481.68 2019091113313166000_31.12.1481.113 2019091113313166000_31.12.1481.66 2019091113313166000_31.12.1481.111 2019091113313166000_31.12.1481.65 2019091113313166000_31.12.1481.112 (2019091113313166000_31.12.1481.50) 1997; 23 2019091113313166000_31.12.1481.108 (2019091113313166000_31.12.1481.95) 1988; 263 (2019091113313166000_31.12.1481.25) 1989; 10 (2019091113313166000_31.12.1481.21) 1976; 60 2019091113313166000_31.12.1481.52 (2019091113313166000_31.12.1481.1) 1981; 8 2019091113313166000_31.12.1481.106 2019091113313166000_31.12.1481.107 2019091113313166000_31.12.1481.59 (2019091113313166000_31.12.1481.87) 1985; 15 2019091113313166000_31.12.1481.104 2019091113313166000_31.12.1481.57 2019091113313166000_31.12.1481.102 2019091113313166000_31.12.1481.55 2019091113313166000_31.12.1481.54 2019091113313166000_31.12.1481.101 (2019091113313166000_31.12.1481.27) 1986; 70 (2019091113313166000_31.12.1481.58) 1995; 27 2019091113313166000_31.12.1481.86 2019091113313166000_31.12.1481.85 2019091113313166000_31.12.1481.84 2019091113313166000_31.12.1481.82 (2019091113313166000_31.12.1481.36) 1987; 15 2019091113313166000_31.12.1481.81 2019091113313166000_31.12.1481.80 (2019091113313166000_31.12.1481.89) 1984; 44 2019091113313166000_31.12.1481.88 (2019091113313166000_31.12.1481.41) 1984; 259 (2019091113313166000_31.12.1481.28) 1978; 54 (2019091113313166000_31.12.1481.45) 1978; 38 (2019091113313166000_31.12.1481.83) 1983; 11 (2019091113313166000_31.12.1481.76) 1992; 22 2019091113313166000_31.12.1481.74 (2019091113313166000_31.12.1481.114) 1992; 22 2019091113313166000_31.12.1481.73 2019091113313166000_31.12.1481.70 (2019091113313166000_31.12.1481.23) 1992; 51 2019091113313166000_31.12.1481.79 (2019091113313166000_31.12.1481.64) 1980; 10 2019091113313166000_31.12.1481.78 (2019091113313166000_31.12.1481.4) 1996; 124 2019091113313166000_31.12.1481.20 (2019091113313166000_31.12.1481.47) 1977; 21 2019091113313166000_31.12.1481.24 2019091113313166000_31.12.1481.22 (2019091113313166000_31.12.1481.77) 1984; 121 2019091113313166000_31.12.1481.18 2019091113313166000_31.12.1481.96 2019091113313166000_31.12.1481.94 2019091113313166000_31.12.1481.93 2019091113313166000_31.12.1481.92 2019091113313166000_31.12.1481.91 2019091113313166000_31.12.1481.90 2019091113313166000_31.12.1481.17 (2019091113313166000_31.12.1481.72) 1980; 255 2019091113313166000_31.12.1481.16 2019091113313166000_31.12.1481.15 2019091113313166000_31.12.1481.14 (2019091113313166000_31.12.1481.19) 1977; 46 (2019091113313166000_31.12.1481.103) 1987; 242 2019091113313166000_31.12.1481.13 2019091113313166000_31.12.1481.12 (2019091113313166000_31.12.1481.3) 1978; 6 2019091113313166000_31.12.1481.11 2019091113313166000_31.12.1481.99 2019091113313166000_31.12.1481.10 2019091113313166000_31.12.1481.98 (2019091113313166000_31.12.1481.75) 1978; 6 (2019091113313166000_31.12.1481.109) 1987; 47 (2019091113313166000_31.12.1481.38) 1965; 77 (2019091113313166000_31.12.1481.105) 1988; 48 2019091113313166000_31.12.1481.2 2019091113313166000_31.12.1481.7 (2019091113313166000_31.12.1481.71) 1985; 45 2019091113313166000_31.12.1481.8 2019091113313166000_31.12.1481.5 (2019091113313166000_31.12.1481.53) 1987; 110 2019091113313166000_31.12.1481.6 2019091113313166000_31.12.1481.42 2019091113313166000_31.12.1481.40 (2019091113313166000_31.12.1481.51) 1986; 110 2019091113313166000_31.12.1481.49 2019091113313166000_31.12.1481.48 2019091113313166000_31.12.1481.46 2019091113313166000_31.12.1481.44 2019091113313166000_31.12.1481.43 (2019091113313166000_31.12.1481.56) 1984; 4 2019091113313166000_31.12.1481.31 2019091113313166000_31.12.1481.30 2019091113313166000_31.12.1481.39 2019091113313166000_31.12.1481.37 (2019091113313166000_31.12.1481.67) 1984; 2 (2019091113313166000_31.12.1481.97) 1985; 233 2019091113313166000_31.12.1481.35 2019091113313166000_31.12.1481.34 2019091113313166000_31.12.1481.33 2019091113313166000_31.12.1481.32 2019091113313166000_31.12.1481.29 (2019091113313166000_31.12.1481.100) 1990; 50 (2019091113313166000_31.12.1481.9) 1981; 33 (2019091113313166000_31.12.1481.26) 1995; 48 |
References_xml | – ident: 2019091113313166000_31.12.1481.44 doi: 10.1016/0006-2952(69)90050-1 – ident: 2019091113313166000_31.12.1481.93 doi: 10.1093/carcin/2.8.731 – volume: 242 start-page: 312 year: 1987 ident: 2019091113313166000_31.12.1481.103 publication-title: J Pharmacol Exp Ther – ident: 2019091113313166000_31.12.1481.112 doi: 10.1021/cr60211a004 – volume: 10 start-page: 139 year: 1989 ident: 2019091113313166000_31.12.1481.25 publication-title: Rev Biochem Toxicol – volume: 48 start-page: 1078 year: 1995 ident: 2019091113313166000_31.12.1481.26 publication-title: Mol Pharmacol – ident: 2019091113313166000_31.12.1481.81 doi: 10.1021/bi00517a017 – ident: 2019091113313166000_31.12.1481.91 doi: 10.1016/0024-3205(86)90191-8 – volume: 38 start-page: 2438 year: 1978 ident: 2019091113313166000_31.12.1481.45 publication-title: Cancer Res – ident: 2019091113313166000_31.12.1481.43 doi: 10.1021/bi010395e – volume: 110 start-page: 2018 year: 1987 ident: 2019091113313166000_31.12.1481.53 publication-title: J Am Chem Soc – volume: 6 start-page: 363 year: 1978 ident: 2019091113313166000_31.12.1481.75 publication-title: Drug Metab Dispos – volume: 4 start-page: 1143 year: 1984 ident: 2019091113313166000_31.12.1481.56 publication-title: Hepatology doi: 10.1002/hep.1840040609 – ident: 2019091113313166000_31.12.1481.46 doi: 10.1016/0006-291X(77)90758-6 – ident: 2019091113313166000_31.12.1481.34 doi: 10.1007/978-1-4684-5877-0_9 – ident: 2019091113313166000_31.12.1481.48 doi: 10.1093/mutage/4.5.355 – ident: 2019091113313166000_31.12.1481.69 doi: 10.1021/ja00214a060 – ident: 2019091113313166000_31.12.1481.59 doi: 10.1021/bi00449a009 – ident: 2019091113313166000_31.12.1481.99 doi: 10.1021/tx9501187 – ident: 2019091113313166000_31.12.1481.18 – ident: 2019091113313166000_31.12.1481.54 doi: 10.1021/ja00118a001 – volume: 45 start-page: 6280 year: 1985 ident: 2019091113313166000_31.12.1481.71 publication-title: Cancer Res – ident: 2019091113313166000_31.12.1481.88 doi: 10.1016/0024-3205(78)90668-9 – ident: 2019091113313166000_31.12.1481.68 doi: 10.1097/00000542-197909001-00105 – volume: 124 start-page: 726 year: 1996 ident: 2019091113313166000_31.12.1481.4 publication-title: Ann Intern Med doi: 10.7326/0003-4819-124-8-199604150-00004 – ident: 2019091113313166000_31.12.1481.85 doi: 10.1021/ja00218a045 – ident: 2019091113313166000_31.12.1481.31 doi: 10.1021/bi00531a026 – ident: 2019091113313166000_31.12.1481.60 doi: 10.1016/0006-2952(78)90143-0 – ident: 2019091113313166000_31.12.1481.101 doi: 10.1021/bi00371a015 – volume: 11 start-page: 164 year: 1983 ident: 2019091113313166000_31.12.1481.83 publication-title: Drug Metab Dispos – volume: 2 start-page: 255 year: 1984 ident: 2019091113313166000_31.12.1481.67 publication-title: J Chem Soc Perkin Trans – ident: 2019091113313166000_31.12.1481.111 doi: 10.1021/jm00196a009 – ident: 2019091113313166000_31.12.1481.37 doi: 10.1016/0006-291X(78)91643-1 – volume: 21 start-page: 165 year: 1977 ident: 2019091113313166000_31.12.1481.47 publication-title: Environ Health Perspect doi: 10.1289/ehp.7721165 – ident: 2019091113313166000_31.12.1481.78 doi: 10.1021/bi00683a013 – ident: 2019091113313166000_31.12.1481.86 doi: 10.1093/carcin/15.8.1487 – ident: 2019091113313166000_31.12.1481.84 doi: 10.1021/bi00472a030 – ident: 2019091113313166000_31.12.1481.82 doi: 10.1016/0041-008X(88)90388-2 – ident: 2019091113313166000_31.12.1481.102 doi: 10.1093/carcin/4.7.821 – ident: 2019091113313166000_31.12.1481.2 – ident: 2019091113313166000_31.12.1481.115 doi: 10.1021/tx00011a001 – ident: 2019091113313166000_31.12.1481.11 doi: 10.1016/0014-5793(96)00267-0 – ident: 2019091113313166000_31.12.1481.20 doi: 10.3109/10409238209108715 – volume: 77 start-page: 334 year: 1965 ident: 2019091113313166000_31.12.1481.38 publication-title: J Am Chem Soc – volume: 121 start-page: 213 year: 1984 ident: 2019091113313166000_31.12.1481.77 publication-title: Biochem Biophys Res Commun doi: 10.1016/0006-291X(84)90709-5 – ident: 2019091113313166000_31.12.1481.6 doi: 10.1021/ja00246a038 – ident: 2019091113313166000_31.12.1481.107 doi: 10.1006/faat.1995.1152 – ident: 2019091113313166000_31.12.1481.108 doi: 10.1093/carcin/12.4.545 – ident: 2019091113313166000_31.12.1481.79 – ident: 2019091113313166000_31.12.1481.74 doi: 10.1016/0003-9861(83)90178-9 – ident: 2019091113313166000_31.12.1481.117 doi: 10.1021/bi000869u – volume: 15 start-page: 589 year: 1987 ident: 2019091113313166000_31.12.1481.36 publication-title: Drug Metab Dispos – ident: 2019091113313166000_31.12.1481.8 doi: 10.1021/ja983000w – ident: 2019091113313166000_31.12.1481.12 doi: 10.1039/cs9740300513 – volume: 47 start-page: 3373 year: 1987 ident: 2019091113313166000_31.12.1481.109 publication-title: Cancer Res – volume: 22 start-page: 1157 year: 1992 ident: 2019091113313166000_31.12.1481.76 publication-title: Xenobiotica doi: 10.3109/00498259209051869 – ident: 2019091113313166000_31.12.1481.39 doi: 10.1021/ja00310a066 – volume: 255 start-page: 6049 year: 1980 ident: 2019091113313166000_31.12.1481.72 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)43699-X – ident: 2019091113313166000_31.12.1481.61 – ident: 2019091113313166000_31.12.1481.10 doi: 10.1021/tx00004a001 – ident: 2019091113313166000_31.12.1481.92 doi: 10.1016/0009-2797(79)90077-2 – ident: 2019091113313166000_31.12.1481.14 doi: 10.1016/0041-008X(81)90363-X – ident: 2019091113313166000_31.12.1481.35 doi: 10.1016/0041-008X(82)90387-8 – ident: 2019091113313166000_31.12.1481.98 doi: 10.1021/ja00354a044 – ident: 2019091113313166000_31.12.1481.90 doi: 10.1016/S0300-483X(01)00376-6 – ident: 2019091113313166000_31.12.1481.30 doi: 10.1016/0009-2797(74)90128-8 – ident: 2019091113313166000_31.12.1481.65 doi: 10.1093/jnci/68.4.681 – volume: 33 start-page: 81 year: 1981 ident: 2019091113313166000_31.12.1481.9 publication-title: J Pharmacol Exp Ther – volume: 233 start-page: 857 year: 1985 ident: 2019091113313166000_31.12.1481.97 publication-title: J Pharmacol Exp Ther – volume: 6 start-page: 556 year: 1978 ident: 2019091113313166000_31.12.1481.3 publication-title: Drug Metab Dispos – ident: 2019091113313166000_31.12.1481.96 doi: 10.1006/bioo.2002.1239 – volume: 46 start-page: 265 year: 1977 ident: 2019091113313166000_31.12.1481.19 publication-title: Mutat Res doi: 10.1016/0165-1161(77)90003-6 – volume: 110 start-page: 2018 year: 1986 ident: 2019091113313166000_31.12.1481.51 publication-title: J Am Chem Soc – volume: 15 start-page: 135 year: 1985 ident: 2019091113313166000_31.12.1481.87 publication-title: Drug Metab Rev – ident: 2019091113313166000_31.12.1481.57 doi: 10.1093/carcin/5.8.1009 – ident: 2019091113313166000_31.12.1481.42 doi: 10.1016/0300-483X(95)03116-W – ident: 2019091113313166000_31.12.1481.113 doi: 10.1016/0041-008X(83)90297-1 – volume: 70 start-page: 811 year: 1986 ident: 2019091113313166000_31.12.1481.27 publication-title: Cancer Treat Rep – ident: 2019091113313166000_31.12.1481.40 doi: 10.1021/ja00074a001 – ident: 2019091113313166000_31.12.1481.70 – ident: 2019091113313166000_31.12.1481.22 doi: 10.1021/bi00176a025 – ident: 2019091113313166000_31.12.1481.116 doi: 10.1016/0041-008X(85)90089-4 – ident: 2019091113313166000_31.12.1481.33 doi: 10.1021/bi00176a024 – ident: 2019091113313166000_31.12.1481.16 doi: 10.1016/0006-2952(80)90624-3 – ident: 2019091113313166000_31.12.1481.66 doi: 10.1093/jnci/57.6.1311 – ident: 2019091113313166000_31.12.1481.29 doi: 10.1002/1097-0142(197512)36:6<2407::AID-CNCR2820360620>3.0.CO;2-W – ident: 2019091113313166000_31.12.1481.73 doi: 10.1016/0041-008X(83)90310-1 – ident: 2019091113313166000_31.12.1481.94 doi: 10.1021/tx0100237 – ident: 2019091113313166000_31.12.1481.104 doi: 10.1093/carcin/6.6.873 – volume: 50 start-page: 1144 year: 1990 ident: 2019091113313166000_31.12.1481.100 publication-title: Cancer Res – ident: 2019091113313166000_31.12.1481.5 doi: 10.1006/taap.1994.1193 – ident: 2019091113313166000_31.12.1481.49 doi: 10.1016/0041-008X(87)90306-1 – ident: 2019091113313166000_31.12.1481.17 doi: 10.1016/0009-2797(75)90098-8 – volume: 54 start-page: 265 year: 1978 ident: 2019091113313166000_31.12.1481.28 publication-title: Mutat Res doi: 10.1016/0165-1161(78)90016-X – volume: 8 start-page: 105 year: 1981 ident: 2019091113313166000_31.12.1481.1 publication-title: J Toxicol Environ Health doi: 10.1080/15287398109530054 – ident: 2019091113313166000_31.12.1481.15 doi: 10.1021/jm00229a019 – ident: 2019091113313166000_31.12.1481.106 doi: 10.1093/carcin/15.6.1197 – ident: 2019091113313166000_31.12.1481.24 doi: 10.1016/0163-7258(85)90072-5 – ident: 2019091113313166000_31.12.1481.32 doi: 10.1016/0024-3205(91)90573-T – volume: 60 start-page: 483 year: 1976 ident: 2019091113313166000_31.12.1481.21 publication-title: Cancer Treat Rep – volume: 51 start-page: 569 year: 1992 ident: 2019091113313166000_31.12.1481.23 publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-199211000-00001 – ident: 2019091113313166000_31.12.1481.63 doi: 10.1016/0304-3835(84)90023-5 – ident: 2019091113313166000_31.12.1481.80 doi: 10.1146/annurev.bi.50.070181.000535 – ident: 2019091113313166000_31.12.1481.7 doi: 10.1021/bi00405a033 – volume: 10 start-page: 325 year: 1980 ident: 2019091113313166000_31.12.1481.64 publication-title: Cancer Res – volume: 22 start-page: 1165 year: 1992 ident: 2019091113313166000_31.12.1481.114 publication-title: Xenobiotica doi: 10.3109/00498259209051870 – volume: 27 start-page: 45 year: 1995 ident: 2019091113313166000_31.12.1481.58 publication-title: Drug Metab Rev doi: 10.3109/03602539509029814 – ident: 2019091113313166000_31.12.1481.110 doi: 10.1021/tx00046a010 – volume: 23 start-page: 7136 year: 1997 ident: 2019091113313166000_31.12.1481.50 publication-title: Biochemistry – ident: 2019091113313166000_31.12.1481.52 doi: 10.1021/jm00166a024 – ident: 2019091113313166000_31.12.1481.62 doi: 10.1093/carcin/3.11.1289 – volume: 48 start-page: 2162 year: 1988 ident: 2019091113313166000_31.12.1481.105 publication-title: Cancer Res – volume: 44 start-page: 543 year: 1984 ident: 2019091113313166000_31.12.1481.89 publication-title: Cancer Res – volume: 263 start-page: 13733 year: 1988 ident: 2019091113313166000_31.12.1481.95 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)68302-4 – volume: 259 start-page: 3005 year: 1984 ident: 2019091113313166000_31.12.1481.41 publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)43249-2 – ident: 2019091113313166000_31.12.1481.13 doi: 10.1021/tx00013a011 – ident: 2019091113313166000_31.12.1481.55 doi: 10.1093/jnci/51.1.299 |
SSID | ssj0014439 |
Score | 2.1843936 |
SecondaryResourceType | review_article |
Snippet | Critical elements from studies that have led to our current understanding of the factors that cause the observed primary deuterium
isotope effect, (k H /k D... Critical elements from studies that have led to our current understanding of the factors that cause the observed primary deuterium isotope effect, (kH/kD)obs,... Critical elements from studies that have led to our current understanding of the factors that cause the observed primary deuterium isotope effect, (k sub(H)/k... |
SourceID | proquest crossref pubmed pascalfrancis highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1481 |
SubjectTerms | Analytical, structural and metabolic biochemistry Animals Binding Sites Biological and medical sciences Catalysis Cytochrome P-450 Enzyme System - metabolism Deuterium - chemistry Drug-Related Side Effects and Adverse Reactions Enzymes and enzyme inhibitors Fundamental and applied biological sciences. Psychology Humans Isotope Labeling - methods Kinetics Lyases Pharmaceutical Preparations - chemistry Pharmaceutical Preparations - metabolism Structure-Activity Relationship |
Title | THE USE OF DEUTERIUM ISOTOPE EFFECTS TO PROBE THE ACTIVE SITE PROPERTIES, MECHANISM OF CYTOCHROME P450-CATALYZED REACTIONS, AND MECHANISMS OF METABOLICALLY DEPENDENT TOXICITY |
URI | http://dmd.aspetjournals.org/content/31/12/1481.abstract https://www.ncbi.nlm.nih.gov/pubmed/14625345 https://search.proquest.com/docview/17907966 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF615cIF8SY8yhxQOSQGe71-HRFNhVAVIiUVvVnOet1GauKotiXCj-I3MuO1vbYEAg5crGjtGVmeL7Pz2hnG3gjXlREPHcsJgsQSofKslUx8S0nazSIvyWQ9xHYRzC7D06mYHhy0kzLN2n-VNK6hrOnk7D9Iu2OKC_gbZY5XlDpe_1rulQ7Qp4rmNayrzXhd5GW-M9UbaHDSJBlVm51JrfLGlEam1R1VWmvlsVF0LpjGaFDx-b7M5TV1NxjPhWdbdeBn_13R8Rd9OqJoS0E7ukKn70tEGgUHb27243bqbokv8W0t1-Ugr3x6W111BM34jnTdlZaZ0HXbZHJhSpZx273SAPza1Cu30Qy3VxnSaOjItiJPNxtvNbTr9JHIe_oWnTmnt3ejuxf8el_gAgWXbtJ3rkPhX0PXb8A9-xKfXZyfx8vp5fKQ3eGou0h1Lj7PusSUEK72qJrXbPqAIv_3Q-5DO6ftPU2lt0mB3zvTY1N-79fU9s3yPrvXOCbwQSPqATtQ24fsZK47m-8nsDQH9YoJnMDc9DzfP2I_8DYg7CDPoIMdNLCDBnZQ5lDDDhB2oGEHBDswsJtABx7iZUAHQ9BBB7oJIEgMVUFkA8hBBzloIfeYXZxNlx8_Wc0oEEsi89JCuzuwFSmQOg-NNnEY2ekKbXdOPoadUdNTV3J8TgRo94VRwDOZyJWTJL4jufuEHW3zrXrGIPWk4DxIVkGqhKIkZJoF3A5TpPVD7o3Y21Zw8U53fIlrT5mLGEUcu07s8JhEPGLQyjXe9T764JHjgbwNRw93UnRvRux1C4AYFTtl65KtyqsiptZ5QeT7I_ZU48LQCp97rvCe_5H2Bbtr_mQv2VF5W6lX7LBIq-Ma1j8BPyPQFw |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Multiple Vendors |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+use+of+deuterium+isotope+effects+to+probe+the+active+site+properties%2C+mechanism+of+cytochrome+P450-catalyzed+reactions%2C+and+mechanisms+of+metabolically+dependent+toxicity&rft.jtitle=Drug+metabolism+and+disposition&rft.au=Nelson%2C+S+D&rft.au=Trager%2C+W+F&rft.date=2003-12-01&rft.issn=0090-9556&rft.volume=31&rft.issue=12&rft.spage=1481&rft.epage=1497&rft_id=info:doi/10.1124%2Fdmd.31.12.1481&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-9556&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-9556&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-9556&client=summon |